Strs Ohio boosted its stake in shares of Chemed Co. (NYSE:CHE) by 45.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,890 shares of the company’s stock after purchasing an additional 1,211 shares during the quarter. Strs Ohio’s holdings in Chemed were worth $1,754,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of CHE. Cubist Systematic Strategies LLC boosted its position in Chemed by 50.2% during the fourth quarter. Cubist Systematic Strategies LLC now owns 1,953 shares of the company’s stock valued at $858,000 after purchasing an additional 653 shares in the last quarter. Ladenburg Thalmann Financial Services Inc. boosted its position in Chemed by 38.6% during the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,350 shares of the company’s stock valued at $401,000 after purchasing an additional 376 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Chemed by 0.3% in the fourth quarter. Geode Capital Management LLC now owns 205,409 shares of the company’s stock worth $90,226,000 after acquiring an additional 534 shares in the last quarter. Sunbelt Securities Inc. acquired a new stake in Chemed in the fourth quarter worth about $11,873,000. Finally, Pearl River Capital LLC acquired a new stake in Chemed in the fourth quarter worth about $239,000. 88.73% of the stock is currently owned by institutional investors.

In other news, CEO Kevin J. Mcnamara sold 7,000 shares of the firm’s stock in a transaction dated Wednesday, May 13th. The stock was sold at an average price of $431.36, for a total value of $3,019,520.00. Following the completion of the transaction, the chief executive officer now directly owns 143,727 shares in the company, valued at $61,998,078.72. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Donald E. Saunders sold 300 shares of the firm’s stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $475.53, for a total value of $142,659.00. Following the completion of the transaction, the director now owns 6,736 shares of the company’s stock, valued at $3,203,170.08. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,020 shares of company stock valued at $7,212,353. Company insiders own 3.96% of the company’s stock.

Separately, Zacks Investment Research raised Chemed from a “hold” rating to a “buy” rating and set a $489.00 price target for the company in a report on Tuesday, May 19th. One analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $509.80.

Shares of NYSE CHE opened at $492.19 on Friday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.78 and a current ratio of 0.59. The company has a market cap of $7.88 billion, a PE ratio of 31.49, a P/E/G ratio of 3.10 and a beta of 0.70. The business has a 50-day simple moving average of $462.10 and a two-hundred day simple moving average of $451.92. Chemed Co. has a fifty-two week low of $330.01 and a fifty-two week high of $513.75.

Chemed (NYSE:CHE) last announced its quarterly earnings data on Wednesday, July 29th. The company reported $4.41 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.75 by $0.66. Chemed had a return on equity of 36.71% and a net margin of 12.99%. The firm had revenue of $502.20 million during the quarter, compared to analysts’ expectations of $522.90 million. During the same period last year, the business posted $3.36 earnings per share. The company’s revenue for the quarter was up 6.0% compared to the same quarter last year. On average, sell-side analysts predict that Chemed Co. will post 16.31 earnings per share for the current fiscal year.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates through two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned and independent contractors, and franchised locations.

Further Reading: What is Net Asset Value (NAV)?

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHE).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.